Insulin is a key hormone involved in the regulation of overall energetic homeostasis of the organism. The dimeric character of the receptor for insulin evokes ideas about its activation or inhibition with peptide dimers that could either trigger or block the structural transition of the insulin receptor, leading to its activation. Herewith, we present the chemical engineering and biological characterization of several series of insulin dimers or dimers of specific peptides that should be able to bind receptors for insulin or insulin growth factor 1. The hormones or peptides in the dimers were interconnected with different linkers, consisting of triazole moieties and 3, 6, 8, 11, or 23 polyethylene glycol units. The prepared dimers were weaker in binding to insulin receptors than human insulin. However, some of the insulin dimers showed preferential binding specificity toward the isoform A of the insulin receptor, and the insulin dimers also stimulated the insulin receptor more strongly than would be consistent with their binding affinities. Our results suggest that designing insulin dimers may be a promising strategy for modulating the ability of the hormone to activate the receptor or to alter its specificity toward insulin receptor isoforms.

Department of Biochemistry Faculty of Science Charles University Prague Czech Republic

Institute of Organic Chemistry and Biochemistry Czech Academy of Sciences Prague Czech Republic

Regional Center of Advanced Technologies and Materials Czech Advanced Technology and Research Institute Palacký University Olomouc Olomouc Czech Republic

Zobrazit více v PubMed

Saltiel AR. Insulin signaling in health and disease. J Clin Invest. 2021;131(1):e142241. doi:10.1172/JCI142241

De Meyts P. Insulin and its receptor: structure, function and evolution. Bioessays. 2004;26(12):1351-1362. doi:10.1002/bies.20151

Le Roith D. The insulin-like growth factor system. Exp Diabesity Res. 2003;4(4):205-212. doi:10.1155/EDR.2003.205

LeRoith D, Holly JMP, Forbes BE. Insulin-like growth factors: ligands, binding proteins, and receptors. Mol Metab. 2021;52:101245. doi:10.1016/j.molmet.2021.101245

Nagao H, Cai W, Wewer Albrechtsen NJ, et al. Distinct signaling by insulin and IGF-1 receptors and their extra- and intracellular domains. Proc Natl Acad Sci USA. 2021;118(17):e2019474118. doi:10.1073/pnas.2019474118

Belfiore A, Malaguarnera R, Vella V, et al. Insulin receptor isoforms in physiology and disease: an updated view. Endocr Rev. 2017;38(5):379-431. doi:10.1210/er.2017-00073

Ward CW, Lawrence MC. Similar but different: ligand-induced activation of the insulin and epidermal growth factor receptor families. Curr Opin Struct Biol. 2012;22(3):360-366. doi:10.1016/j.sbi.2012.03.014

Lemmon MA, Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell. 2010;141(7):1117-1134. doi:10.1016/j.cell.2010.06.011

Ullrich A, Gray A, Tam AW, et al. Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J. 1986;5(10):2503-2512. doi:10.1002/j.1460-2075.1986.tb04528.x

Lawrence MC, McKern NM, Ward CW. Insulin receptor structure and its implications for the IGF-1 receptor. Curr Opin Struct Biol. 2007;17(6):699-705. doi:10.1016/j.sbi.2007.07.007

De Meyts P. The structural basis of insulin and insulin-like growth factor-I receptor binding and negative co-operativity, and its relevance to mitogenic versus metabolic signalling. Diabetologia. 1994;37(Suppl 2):S135-S148. doi:10.1007/BF00400837

Lawrence MC. Understanding insulin and its receptor from their three-dimensional structures. Mol Metab. 2021;52:101255. doi:10.1016/j.molmet.2021.101255

Nielsen J, Brandt J, Boesen T, et al. Structural investigations of full-length insulin receptor dynamics and Signalling. J Mol Biol. 2022;434(5):167458. doi:10.1016/j.jmb.2022.167458

Li J, Park J, Mayer JP, et al. Synergistic activation of the insulin receptor via two distinct sites. Nat Struct Mol Biol. 2022;29(4):357-368. doi:10.1038/s41594-022-00750-6

Li J, Choi E, Yu H, Bai XC. Structural basis of the activation of type 1 insulin-like growth factor receptor. Nat Commun. 2019;10(1):4567. doi:10.1038/s41467-019-12564-0

Gutmann T, Schäfer IB, Poojari C, et al. Cryo-EM structure of the complete and ligand-saturated insulin receptor ectodomain. J Cell Biol. 2020;219(1):1-16. doi:10.1083/jcb.201907210

Uchikawa E, Choi E, Shang GJ, Yu HT, Bai XC. Activation mechanism of the insulin receptor revealed by cryo-EM structure of the fully liganded receptor-ligand complex. Elife. 2019;8:e48630. doi:10.7554/eLife.48630

Menting JG, Whittaker J, Margetts MB, et al. How insulin engages its primary binding site on the insulin receptor. Nature. 2013;493(7431):241-245. doi:10.1038/nature11781

Menting JG, Lawrence CF, Kong GKW, Margetts MB, Ward CW, Lawrence MC. Structural congruency of ligand binding to the insulin and insulin/type 1 insulin-like growth factor hybrid receptors. Structure. 2015;23(7):1271-1282. doi:10.1016/j.str.2015.04.016

Schuttler A, Brandenburg D. Preparation and properties of covalently linked insulin dimers. Hoppe Seylers Z Physiol Chem. 1982;363(1):317-330. doi:10.1515/bchm2.1982.363.1.317

Tatnell MA, Jones RH, Willey KP, Schuttler A, Brandenburg D. Evidence concerning the mechanism of insulin-receptor interaction and the structure of the insulin-receptor from biological properties of covalently linked insulin dimers. Biochem J. 1983;216(3):687-694. doi:10.1042/bj2160687

Weiland M, Brandenburg C, Brandenburg D, Joost HG. Antagonistic effects of a covalently dimerized insulin derivative on insulin-receptors in 3T3-L1 adipocytes. Proc Natl Acad Sci USA. 1990;87(3):1154-1158. doi:10.1073/pnas.87.3.1154

Pissarnitski DA, Kekec A, Yan L, et al. Discovery of insulin receptor partial agonists MK-5160 and MK-1092 as novel basal insulins with potential to improve therapeutic index. J Med Chem. 2022;65(7):5593-5605. doi:10.1021/acs.jmedchem.1c02073

Wu M, Carballo-Jane E, Zhou H, et al. Functionally selective signaling and broad metabolic benefits by novel insulin receptor partial agonists. Nat Commun. 2022;13(1):942. doi:10.1038/s41467-022-28561-9

Chen D, Disotuar MM, Xiong X, Wang Y, Chou DH. Selective N-terminal functionalization of native peptides and proteins. Chem Sci. 2017;8(4):2717-2722. doi:10.1039/C6SC04744K

Panikova T, Mitrova K, Halamova T, et al. Insulin analogues with altered insulin receptor isoform binding specificities and enhanced aggregation stabilities. J Med Chem. 2021;64(19):14848-14859. doi:10.1021/acs.jmedchem.1c01388

Asai S, Zakova L, Selicharova I, Marek A, Jiracek J. A radioligand receptor binding assay for measuring of insulin secreted by MIN6 cells after stimulation with glucose, arginine, ornithine, dopamine, and serotonin. Anal Bioanal Chem. 2021;413(17):4531-4543. doi:10.1007/s00216-021-03423-3

Hexnerova R, Krizkova K, Fabry M, et al. Probing receptor specificity by sampling the conformational space of the insulin-like growth factor II C-domain. J Biol Chem. 2016;291(40):21234-21245. doi:10.1074/jbc.M116.741041

Krizkova K, Chrudinova M, Povalova A, et al. Insulin-insulin-like growth factors hybrids as molecular probes of hormone:receptor binding specificity. Biochemistry. 2016;55(21):2903-2913. doi:10.1021/acs.biochem.6b00140

Machackova K, Collinsova M, Chrudinova M, et al. Insulin-like growth factor 1 analogs clicked in the C domain: chemical synthesis and biological activities. J Med Chem. 2017;60(24):10105-10117. doi:10.1021/acs.jmedchem.7b01331

Fryszkowska A, An C, Alvizo O, et al. A chemoenzymatic strategy for site-selective functionalization of native peptides and proteins. Science. 2022;376(6599):1321-1327. doi:10.1126/science.abn2009

Kristensen C, Kjeldsen T, Wiberg FC, et al. Alanine scanning mutagenesis of insulin. J Biol Chem. 1997;272(20):12978-12983. doi:10.1074/jbc.272.20.12978

Gauguin L, Klaproth B, Sajid W, et al. Structural basis for the lower affinity of the insulin-like growth factors for the insulin receptor. J Biol Chem. 2008;283(5):2604-2613. doi:10.1074/jbc.M709220200

Yang M, Jalloh AS, Wei W, Zhao J, Wu P, Chen PR. Biocompatible click chemistry enabled compartment-specific pH measurement inside E. coli. Nat Commun. 2014;5(1):4981. doi:10.1038/ncomms5981

Vienberg SG, Bouman SD, Sorensen H, et al. Receptor-isoform-selective insulin analogues give tissue-preferential effects. Biochem J. 2011;440(3):301-308. doi:10.1042/BJ20110880

Jiracek J, Zakova L. Structural perspectives of insulin receptor isoform-selective insulin analogs. Front Endocrinol. 2017;8:167. doi:10.3389/fendo.2017.00167

Xu Y, Margetts MB, Venugopal H, et al. How insulin-like growth factor I binds to a hybrid insulin receptor type 1 insulin-like growth factor receptor. Structure. 2022;30(8):1098-1108. doi:10.1016/j.str.2022.05.007

Havenith C. Rheinisch-Westfalischen Technischen Hochschule Aachen (RWTH Aachen), Neue kovalente Insulindimere: Semisynthese und biologische Eigenschaften, PhD Thesis, 1999.

Schaffer L, Brissette RE, Spetzler JC, et al. Assembly of high-affinity insulin receptor agonists and antagonists from peptide building blocks. Proc Natl Acad Sci USA. 2003;100(8):4435-4439. doi:10.1073/pnas.0830026100

McKern NM, Lawrence MC, Streltsov VA, et al. Structure of the insulin receptor ectodomain reveals a folded-over conformation. Nature. 2006;443(7108):218-221. doi:10.1038/nature05106

Croll TI, Smith BJ, Margetts MB, et al. Higher-resolution structure of the human insulin receptor Ectodomain: multi-modal inclusion of the insert domain. Structure. 2016;24(3):469-476. doi:10.1016/j.str.2015.12.014

Lawrence CF, Margetts MB, Menting JG, et al. Insulin mimetic peptide disrupts the primary binding site of the insulin receptor. J Biol Chem. 2016;291(30):15473-15481. doi:10.1074/jbc.M116.732180

Fabre B, Picha J, Selicharova I, et al. Probing Tripodal peptide scaffolds as insulin and IGF-1 receptor ligands. Eur J Org Chem. 2018;2018(37):5193-5201. doi:10.1002/ejoc.201800606

Hajduch J, Fabre B, Klopp B, et al. Multipodal insulin mimetics built on adamantane or proline scaffolds. Bioorg Chem. 2020;107:104548.

Schaffer L. A model for insulin binding to the insulin receptor. Eur J Biochem. 1994;221(3):1127-1132. doi:10.1111/j.1432-1033.1994.tb18833.x

Recombinant Insulin-Like Growth Factor 1 Dimers: Receptor Binding Affinities and Activation Abilities